Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Publisher : springer nature

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.

Authors : Ye, Peng¹ (AUTHOR); Li, Fanghua² (AUTHOR); Wei, Yuanyuan³ (AUTHOR)

Source: Scientific Reports. 7/28/2022, Vol. 12 Issue 1, p1-10. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers.

Authors : Majumder, Avisek¹; Sandhu, Manbir²; Banerji, Debarko³

Source: Scientific Reports. 4/27/2021, Vol. 11 Issue 1, p1-11. 11p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck.

Authors : Wang, Yi-Ping^1,2,3 (AUTHOR) ; Liu, I-Ju² (AUTHOR); Chen, Kai-Chi² (AUTHOR)

Source: Oncogenesis. Aug2021, Vol. 10 Issue 8, p1-9. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum.

Authors : Ruiz-Saenz, A¹; Sandhu, M¹; Carrasco, Y²

Source: Oncogene. 10/8/2015, Vol. 34 Issue 41, p5288-5294. 7p. 1 Color Photograph, 4 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Pharmacological targeting of the pseudokinase Her3.

Authors : Xie, Ting¹; Lim, Sang Min¹; Westover, Kenneth D²

Source: Nature Chemical Biology. Dec2014, Vol. 10 Issue 12, p1006-1012. 7p. 5 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment.

Authors : Park, Y H¹; Jung, H A¹; Choi, M K¹

Source: British Journal of Cancer. 1/21/2014, Vol. 110 Issue 2, p384-391. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.

Authors : Sergina, Natalia V.¹; Rausch, Megan¹; Wang, Donghui¹

Source: Nature. 1/25/2007, Vol. 445 Issue 7126, p437-441. 5p. 4 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.

Authors : Chakrabarty, A.¹; Rexer, B. N.¹; Wang, S. E.²

Source: Oncogene. 9/16/2010, Vol. 29 Issue 37, p5193-5203. 11p. 6 Black and White Photographs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.

Authors : MacLeod, S H¹; Elgadi, M M²; Bossi, G²

Source: Cancer Gene Therapy. Dec2012, Vol. 19 Issue 12, p888-898. 11p. 1 Diagram, 1 Chart, 6 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.

Authors : Memon, A. A.¹ ; Sorensen, B. S.¹; Melgard, P.²

Source: British Journal of Cancer. 12/13/2004, Vol. 91 Issue 12, p2034-2041. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer.

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers.

NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck.

Targeting HER3 by interfering with its Sec61-mediated cotranslational insertion into the endoplasmic reticulum.

Pharmacological targeting of the pseudokinase Her3.

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment.

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3.

HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.

اتصل بنا

اتبع